Smith Asset Management Group LP bought a new position in shares of Tivity Health (NASDAQ:TVTY) during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor bought 8,200 shares of the company’s stock, valued at approximately $325,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. LS Investment Advisors LLC increased its stake in Tivity Health by 170.9% during the 4th quarter. LS Investment Advisors LLC now owns 3,338 shares of the company’s stock worth $122,000 after buying an additional 2,106 shares during the period. Meadow Creek Investment Management LLC increased its stake in Tivity Health by 76.4% during the 4th quarter. Meadow Creek Investment Management LLC now owns 3,472 shares of the company’s stock worth $127,000 after buying an additional 1,504 shares during the period. SG Americas Securities LLC purchased a new stake in Tivity Health during the 1st quarter worth approximately $152,000. M&T Bank Corp purchased a new stake in Tivity Health during the 1st quarter worth approximately $207,000. Finally, Macquarie Group Ltd. purchased a new stake in Tivity Health during the 4th quarter worth approximately $212,000.
Shares of NASDAQ:TVTY opened at $38.20 on Friday. Tivity Health has a 52 week low of $37.60 and a 52 week high of $38.00. The company has a market capitalization of $1.52 billion, a price-to-earnings ratio of 21.50, a PEG ratio of 1.60 and a beta of 0.31.
A number of equities research analysts have commented on the stock. Cantor Fitzgerald reissued a “buy” rating and issued a $53.00 price objective on shares of Tivity Health in a research report on Monday, April 23rd. BidaskClub raised shares of Tivity Health from a “hold” rating to a “buy” rating in a research report on Tuesday, March 6th. Zacks Investment Research downgraded shares of Tivity Health from a “buy” rating to a “hold” rating in a research report on Tuesday, February 27th. Barrington Research increased their price objective on shares of Tivity Health from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Friday, February 23rd. Finally, Chardan Capital reissued a “neutral” rating and issued a $41.00 price objective (down from $44.00) on shares of Tivity Health in a research report on Friday, February 23rd. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $47.11.
In related news, CEO Donato Tramuto sold 20,000 shares of the stock in a transaction on Monday, April 2nd. The shares were sold at an average price of $39.30, for a total value of $786,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders sold a total of 60,000 shares of company stock worth $2,264,000 over the last ninety days. Insiders own 8.42% of the company’s stock.
Tivity Health Company Profile
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.